跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
氟替卡松福莫特罗吸入气雾剂 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Fluticasone Propionate and Formoterol Fumarate Aerosol for Inhalation
Approved
化学药品
Fluticasone Propionate and Formoterol Fumarate Aerosol for Inhalation
NAPP PHARMACEUTICALS LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Sep 12, 2023
Approval ID
8VIZnCVpLbK
Company
NAPP PHARMACEUTICALS LIMITED
Type
化学药品
Approval Details
Approval Id
8VIZnCVpLbK
Approval Number
国药准字HJ20230106
Generic Name
氟替卡松福莫特罗吸入气雾剂
Generic Name En
Fluticasone Propionate and Formoterol Fumarate Aerosol for Inhalation
Drug Type
化学药品
Dosage Form
吸入气雾剂
Strength
每罐120揿,每揿含丙酸氟替卡松50μg和富马酸福莫特罗5μg,递送剂量为丙酸氟替卡松46μg和富马酸福莫特罗4.5μg
Reg Date
2023-09-12
Expired Date
2028-09-11
Company Name
NAPP PHARMACEUTICALS LIMITED
Company Detail Path
/organization/napp-pharmaceuticals-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 12, 2023
Approval ID
8VIZnCVpLbK
Type
化学药品
Back to NMPA Approvals